First UK patients use state-of-the-art Mixed Reality Viewer to visualise and understand their cancer tumour treatment
13 February, 2020
For the first time, patients in the UK will have access to Brainlab Mixed Reality Viewer as part of their cancer treatment; a new way for physicians to provide visualisation of treatment to their patients, actively involving them in their own cancer care. GenesisCare has launched the revolutionary new technology at its Oxford centre for…
13 December, 2019
FLORIDA, U.S. – Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated cancer treatments, 21st Century Oncology, to become part of Australian cancer and cardiac care company, GenesisCare. The combined experience and reach of 21st Century Oncology’s…
10 December, 2019
For the first time, patients in the UK now have access to MRIdian – the world’s smartest radiotherapy treatment – at GenesisCare’s treatment centre in Oxford. This technology combines magnetic resonance imaging (MRI) techniques with extremely precise radiotherapy beams, enabling the clinician to visualise the exact position and shape of a patient’s tumour in real…
14 November, 2019
Our GenesisCare centre in Windsor is rated ‘Outstanding’ by the Care Quality Commission (CQC)
We are delighted to announce that our centre in Windsor has been rated Outstanding in a recent Care Quality Commission (CQC) inspection. The inspectors’ assessment of the centre on 24 to 25 June 2019 covered the five core CQC domains- Safe, effective, caring, responsive and well-led. The CQC inspection evaluated the centre’s key services: outpatient…
13 November, 2019
Latest innovations in prostate cancer treatments in the UK
GenesisCare has recently worked with The Jewish Chronicle to raise awareness of our innovations in prostate cancer treatments in the UK. Read our article that appeared in their November Health Supplement on Thursday 14th November 2019, where we take about the MRIdian Linac, spacing gels and 177Lutetium PSMA therapy. Prostate cancer is the most common…
23 October, 2019
Patients to receive innovative treatments in new state-of-the-art cancer centre
Cancer patients will benefit from a £20 million investment that will see a new state-of-the-art diagnostic and treatment centre built in Surrey. Royal Surrey NHS Foundation Trust is working with specialist oncology group GenesisCare to provide the new facility, which is expected to open in late 2021. Eligible NHS patients and staff will have access…
23 September, 2019
‘New hope for advanced prostate cancer patients’
GenesisCare has recently worked with Health Awareness UK and the Guardian on their Urology Health campaign. Read our article that appeared in the Guardian on Monday 23rd September 2019 where Yong Du, Clinical Director, Nuclear Medicine and Theranostics talks about how 177Lutetium PSMA therapy works and it’s benefits to men with late stage prostate cancer…
16 September, 2019
GenesisCare expands its UK oncology network to bring world-class cancer care to patients in Bristol
The leading provider of private cancer care in the UK will offer patients in Bristol the latest cancer treatments, delivered within its globally-renowned network GenesisCare has signed a deal to acquire Spire’s operating oncology site in Bristol and has entered into a separate partnership to deliver services jointly from the Spire Bristol Hospital The ‘GenesisCare…
12 September, 2019
‘It’s time that breast cancer care got personal’
GenesisCare has recently worked with Health Awareness UK and the Guardian on their Breast Health campaign. In the article that appeared in the Guardian on Tuesday 10th September 2019 our Chief Medical Officer Dr Penny Kechagioglou, Simon Smith (Surgical Clinical Director) and Eliot Sims (Clinical Director, Breast Oncology) discuss the importance of early detection, the…
20 August, 2019
GenesisCare have many exciting opportunities… At GenesisCare we prescribe exercise as an integral part of our cancer care. Before, during and after patients treatment. Doctors used to think that rest was the right answer. However, research shows that staying active can improve long term cancer survival rates and can also reduce the risk of the…
